TCIM
JNCE

TIAA CREF Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

TIAA CREF Investment Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.11M Buy
2018
Q4 		$85K Hold
2018
Q3 		$164K Sell
2018
Q2 		$213K Sell
2018
Q1 		$643K Hold
2017
Q4 		$367K Sell
2017
Q3 		$657K Sell
2017
Q2 		$905K Buy
2017
Q1 		$229K Buy